Published in
Springer Nature [academic journals on nature.com], Leukemia, 2023
DOI: 10.1038/s41375-023-02110-9
Links
Tools
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
Journal article published in 2023 by
Tracy Murphy,
Jacqueline M. Mason 
,
Brian Leber,
Mark R. Bray,
Steven M. Chan,
Vikas Gupta ,
Dina Khalaf,
Dawn Maze ,
Caroline J. McNamara,
Aaron D. Schimmer ,
Andre C. Schuh,
Hassan Sibai,
Michael Trus,
Debbie Valiquette,
Kylie Martin
and other authors.
,
Brian Leber,
Mark R. Bray,
Steven M. Chan,
Vikas Gupta ,
Dina Khalaf,
Dawn Maze ,
Caroline J. McNamara,
Aaron D. Schimmer ,
Andre C. Schuh,
Hassan Sibai,
Michael Trus,
Debbie Valiquette,
Kylie Martin
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 